Error: Could not add to watchlist. X

Anthera Pharmaceuticals Inc

+ Watchlist
ANTH:US
NASDAQ GM
5.84
USD
0.07
1.21%
As of 20:10:00 ET on 06/02/2015.
Open
5.78
Day Range
5.65 - 5.99
Volume
565,599
Previous Close
5.77
52Wk Range
1.46 - 6.37
1 Yr Return
86.58%
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-1.22
Market Cap (m USD)
209.168
Shares Outstanding (m)
35.816
Price/Sales (TTM)
657.78
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Specialty Pharma
Profile
Anthera Pharmaceuticals Inc. is a biopharmaceutical company. The Company is focused on developing and commercializing anti-inflammatory therapeutics for cardiovascular diseases, lupus and other serious diseases.
ADDRESS
25801 Industrial Boulevard
Suite B
Hayward, CA 94545
United States
PHONE
1-510-856-5600
  • Paul F Truex
    President/CEO/Founder
  • Debra Odink
    Senior VP/CTO
  • Colin Hislop
    Senior VP/Chief Medical Ofcr
  • Klara A Dickinson-Eason
    Senior VP/Chief Regulatory Ofcr
  • May Liu
    Senior VP:Finance & Administration
Show More